Similar to breast cancer, ASCO, CAP and the American Society for Clinical Pathology (ASCP) issued a practice guideline for HER2 testing in gastroesophageal adenocarcinoma in 2017 (52). The gene discussed is ERBB2; the disease is breast carcinoma.